Clal Biotechnology Industries Ltd Strategic Asset Allocation Index
Clal Biotechnology Industries Ltd strategic asset allocation index. Clal Biotechnology Industries Ltd (CBI) has a Strategic Asset Allocation Index of 3.5% as of December 2022. Strategic assets (PP&E of ILA5.09 Million plus long-term investments of ILA-) total ILA5.09 Million, measured against net assets of ILA144.90 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Clal Biotechnology Industries Ltd (CBI) tangible net worth to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Clal Biotechnology Industries Ltd (2007–2022)
Strategic asset allocation index of Clal Biotechnology Industries Ltd from 2007 to 2022. This chart shows how Clal Biotechnology Industries Ltd's Strategic Asset Allocation Index has evolved across 16 annual periods from 2007 to 2022. As of December 2022, the index stands at 3.5%, representing strategic assets of ILA5.09 Million against net assets of ILA144.90 Million ILA.
Clal Biotechnology Industries Ltd Strategic Asset Allocation Index by Year (2007–2022)
Clal Biotechnology Industries Ltd strategic asset allocation index by year from 2007 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Clal Biotechnology Industries Ltd from 2007 to 2022, covering 16 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Clal Biotechnology Industries Ltd worth.
| Year | SAAI | Strategic Assets (ILA) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 3.5% | ILA5.09 Million | ILA5.09 Million | ILA- | ILA144.90 Million | ▼ -1.8 pp |
| 2021 | 5.3% | ILA18.06 Million | ILA18.06 Million | ILA- | ILA338.37 Million | ▲ +2.4 pp |
| 2020 | 2.9% | ILA14.94 Million | ILA14.94 Million | ILA- | ILA513.79 Million | ▼ -0.4 pp |
| 2019 | 3.3% | ILA16.32 Million | ILA16.32 Million | ILA- | ILA497.85 Million | ▼ -21.7 pp |
| 2018 | 25.0% | ILA216.75 Million | ILA7.79 Million | ILA208.96 Million | ILA867.62 Million | ▼ -1.9 pp |
| 2017 | 26.9% | ILA217.23 Million | ILA14.85 Million | ILA202.38 Million | ILA808.20 Million | ▲ +2.8 pp |
| 2016 | 24.1% | ILA181.38 Million | ILA16.54 Million | ILA164.84 Million | ILA752.50 Million | ▲ +7.4 pp |
| 2015 | 16.7% | ILA182.93 Million | ILA17.08 Million | ILA165.85 Million | ILA1.09 Billion | ▲ +2.1 pp |
| 2014 | 14.6% | ILA184.31 Million | ILA10.22 Million | ILA174.09 Million | ILA1.26 Billion | ▲ +4.3 pp |
| 2013 | 10.3% | ILA142.46 Million | ILA10.81 Million | ILA131.65 Million | ILA1.38 Billion | ▲ +9.8 pp |
| 2012 | 0.5% | ILA7.29 Million | ILA7.29 Million | ILA- | ILA1.40 Billion | ▲ +0.3 pp |
| 2011 | 0.2% | ILA2.68 Million | ILA2.68 Million | ILA- | ILA1.11 Billion | ▼ 0.0 pp |
| 2010 | 0.3% | ILA3.38 Million | ILA3.38 Million | ILA- | ILA1.23 Billion | ▼ -0.5 pp |
| 2009 | 0.8% | ILA6.25 Million | ILA6.25 Million | ILA- | ILA782.91 Million | ▼ -0.4 pp |
| 2008 | 1.2% | ILA3.31 Million | ILA3.31 Million | ILA- | ILA274.45 Million | ▲ +0.3 pp |
| 2007 | 0.9% | ILA2.91 Million | ILA2.91 Million | ILA- | ILA309.49 Million | — |